GG
FLNA

Golden Green’s Filana Therapeutics FLNA Stock Holding History

Golden Green’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,445
Closed -$228K – 87
2022
Q3 		$228K Buy
+5,445
New +$147K 0.25% 64
2022
Q2 		– Sell
-14,806
Closed -$550K – 85
2022
Q1 		$550K Sell
14,806
-1,581
-10% -$67K 0.45% 52
2021
Q4 		$716K Sell
16,387
-17,120
-51% -$898K 0.58% 51
2021
Q3 		$2.08M Buy
33,507
+25,721
+330% +$2.15M 1.62% 12
2021
Q2 		$665K Buy
7,786
+2,765
+55% +$148K 0.51% 41
2021
Q1 		$226K Sell
5,021
-10,858
-68% -$427K 0.19% 142
2020
Q4 		$108K Buy
+15,879
New +$142K 0.1% 118

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Golden Green's FLNA Position: Q4 2022 in Review

Golden Green sold out of Filana Therapeutics (FLNA) in Q4 2022, closing a stake of 5,445 shares — an estimated $228K sold.

Golden Green first reported a position in FLNA in Q4 2020 and held it in 7 quarters. The position peaked at $2.08M in Q3 2021. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2022.

  • Golden Green reported no remaining Filana Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Golden Green sold 5,445 Filana Therapeutics shares in Q4 2022, an estimated $228K.
  • Golden Green first reported a position in Filana Therapeutics in Q4 2020 and held it in 7 quarters.
  • Golden Green's Filana Therapeutics position peaked at $2.08M in Q3 2021.
  • 153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2022.

Based on Golden Green's 13F filing for Q4 2022, filed 20 Jan 2023.